American Journal of Nephrology · 2008 · 11 citations · 0 references
MedicineNephrologyPathologyPediatric NephrologyPediatric PathologyRenal PathologyGlomerular DiseasesNephrotic SyndromePediatric Renal PathologyRenal DiseaseCyclophosphamide-based TherapyFrequently Relapsing Nephrotic SyndromeMesangial ProliferationNephrotic Syndrome In ChildhoodNephrotic Syndrome Protein LossPediatric Renal BiopsyRenal Biopsy DiagnosisRenal Biopsy Findings
It is widely believed that the most common morphological lesion in children with the idiopathic nephrotic syndrome who manifest a frequently relapsing steroid-responsive course is the minimal-change lesion. However, there are no prospective renal biopsy studies in such patients to substantiate this assertion. We performed a renal biopsy in all children with early frequently relapsing steroid-responsive nephrotic syndrome during the years 1980-1984. In 16 affected children, only 4 (25%) had minimal-change lesion, 7 had IgM nephropathy, 3 had diffuse mesangial hypercellularity, and 2 had focal segmental glomerulosclerosis. Fourteen of these patients have required immunosuppressive therapy with cyclophosphamide. Long-term follow-up revealed that 10 patients have remained protein free, 4 have persistent proteinuria despite cyclophosphamide therapy, 1 had progressed to end-stage renal disease, and 1 is lost to follow-up. On the basis of these findings, we recommend that all children with nephrotic syndrome and an early frequently relapsing steroid-responsive course undergo a prompt renal biopsy. Such patients constitute a high-risk group with a spectrum of renal histopathological lesions characterized by an unpredictable response to therapy and an unfavorable prognosis.